Features of GERD therapy in obese patients: A review-Reference-Cited by-同舟云学术

Features of GERD therapy in obese patients: A review

Published:2023-07-30 Issue:5 Volume:25 Page:361-367
ISSN:2542-2170
Container-title:Consilium Medicum
language:
Short-container-title:Consilium Medicum

Author:

Bakulina Natalia V.^ORCID,Tikhonov Sergey V.^ORCID,Efremova Anastasia Yu.,Mirtskhulava Vakhtang V.

Abstract

Epidemiological, endoscopic and pathophysiological studies confirm the relationship between obesity and gastroesophageal reflux disease (GERD) and is characterized by a more severe course, has clinical and pathophysiological features. In the treatment of GERD, it is necessary to use an individualized integrated approach, which consists in the combined use of diet therapy, lifestyle changes and drug therapy. The basis of pharmacotherapy for GERD are proton-pump inhibitors that positively affect the quality of life and long-term prognosis. At the same time, pharmacodynamic and pharmacokinetic features determine the advantage of the rabeprazole molecule in obese patients, including the minimal risk of drug-drug interactions.

Publisher

Consilium Medicum

Reference64 articles.

1. Ивашкин В.Т., Трухманов А.С. Эволюция представлений о роли нарушений двигательной функции пищевода в патогенезе гастроэзофагеальной рефлюксной болезни. РЖГГК. 2010;20(2):13-9 [Ivashkin VT, Trukhmanov AS. Evolution of concept of esophageal motor disturbances in pathogenesis of gastroesophageal reflux disease. RZHGGK. 2010;20(2):13-9 (in Russian)].

2. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis

3. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

4. Лазебник Л.Б., Машарова А.А., Бордин Д.С., и др. Результаты многоцентрового исследования «Эпидемиология гастроэзофагеальной рефлюксной болезни в России» («МЭГРЕ»). Терапевтический архив. 2011;83(1):45-50 [Lazebnik LB, Masharova AA, Bordin DS, et al. Results of a multicenter trial “Epidemiology of gastroesophageal reflux disease in Russia” (MEGRE). Terapevticheskii arkhiv. 2011;83(1):45-50 (in Russian)].

5. Clinical and Endoscopic Characteristics of GERD in Obese Patients